Part of OPKO Health, Inc., Waratah Pharmaceuticals, Inc. is a company headquartered in Calgary, AB, Canada, that develops pharmaceutical products. The firm was founded by Susan Dana Jones. Transition Therapeutics, Inc., a subsidiary of OPKO Health, Inc. since September 2016, acquired Waratah Pharmaceuticals, Inc. on January 28, 2002 for $15.46 million.